Pay in 4 interest-free payments of $7.32 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
S2CID 7641257
This process is induced by the interaction between CTLA-4 expressed on Tregs or activated T cells and CD80 or CD86 molecules on the surface of antigen presenting cells (APCs) (234)
The most commonly reported adverse events were gastrointestinal disorders and hypoglycemia in patients with type 2 diabetes concurrently using sulfonylureas, metformin, and/or SGLT-2 inhibitors
ET on Nov 22, 2025 Medication Safety 2 3 What important safety information should I know
US$ 21.70
US$ 26.70
US$ 23.55
US$ 22.89
